Andrew S. Fein
Stock Analyst at HC Wainwright & Co.
(1.73)
# 3,223
Out of 4,944 analysts
5
Total ratings
50%
Success rate
1.24%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Andrew S. Fein
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSM Insmed | Maintains: Buy | $120 → $240 | $121.61 | +97.35% | 1 | Aug 13, 2025 | |
| ARVN Arvinas | Maintains: Buy | $24 → $18 | $7.03 | +156.05% | 1 | Aug 7, 2025 | |
| DAWN Day One Biopharmaceuticals | Maintains: Buy | $36 → $25 | $6.17 | +305.19% | 1 | Aug 6, 2025 | |
| PRTA Prothena Corporation | Reiterates: Buy | $14 | $8.02 | +74.56% | 1 | Aug 5, 2025 | |
| VRTX Vertex Pharmaceuticals | Maintains: Buy | $550 → $478 | $393.62 | +21.44% | 1 | Aug 5, 2025 |
Insmed
Aug 13, 2025
Maintains: Buy
Price Target: $120 → $240
Current: $121.61
Upside: +97.35%
Arvinas
Aug 7, 2025
Maintains: Buy
Price Target: $24 → $18
Current: $7.03
Upside: +156.05%
Day One Biopharmaceuticals
Aug 6, 2025
Maintains: Buy
Price Target: $36 → $25
Current: $6.17
Upside: +305.19%
Prothena Corporation
Aug 5, 2025
Reiterates: Buy
Price Target: $14
Current: $8.02
Upside: +74.56%
Vertex Pharmaceuticals
Aug 5, 2025
Maintains: Buy
Price Target: $550 → $478
Current: $393.62
Upside: +21.44%